Dell rises premarket; Tyson Foods, Nordstrom fall
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Goldman Sachs sidelined on Tyson Foods (TSN) as 1Q miss shows deterioration in profitability
February 7, 2023 7:54 AM ESTGoldman Sachs downgraded Tyson Foods (NYSE: TSN) to a Neutral rating (From BUY) and cut the price target on the stock to $66.00 (from $91.00) following the food companys 1Q23 earnings report. The results revealed a sharp deterioration in profitability across the organization, most notably in Chicken, undermining confidence that the cumulative effect of recent operational and strategic changes could sustainability improve margins and earnings for the... More
AbbVie (ABBV) looks to new drugs to boost sales following Humira competition - WSJ
February 6, 2023 11:17 AM ESTAbbVie (NYSE: ABBV) is looking towards its new drugs to replace Humiria now that its blockbuster immune-disease therapy is facing lower-priced competition, the Wall Street Journal said Monday.
The WSJ said that the drugmaker's Chief Executive, Richard Gonzalez, revealed the company is turning to a pair of next-generation successors to reload the billions of dollars in sales that will be lost.
In... More
